【Golden Biotechnology Corp.】Announcement of the Company's Board of Directors Resolution to Convene the 2026 Annual General Meeting of Shareholders (New Agenda Items Added)
Golden Biotechnology Corp. announced, following a board resolution on April 8, 2026, the addition of agenda items for its Annual General Meeting of Shareholders to be held on May 20, 2026, in Taipei. The new items include amendments to the company's articles of incorporation and the issuance of restricted stock units for employees in 2026. The meeting will also review the 2025 business report, approve financial statements, elect nine directors, and lift non-compete restrictions for new directors. Electronic voting will be available from April 20 to May 17, 2026.
📋 Article Processing Timeline
- 📰 Published: April 8, 2026 at 09:00
- 🔍 Collected: April 9, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: April 15, 2026 at 11:45 (147h 45m after Collected)
1. Date of Board Resolution: 2026/04/08
2. Date of Shareholders' Meeting: 2026/05/20
3. Location of Shareholders' Meeting: 8th Floor Conference Room, No. 65, Lane 77, Xing'ai Road, Neihu District, Taipei City
4. Method of Convening Shareholders' Meeting (Physical Shareholders' Meeting/Video-Assisted Shareholders' Meeting/Video Shareholders' Meeting): Physical Shareholders' Meeting
5. Agenda Item 1: Reporting Matters
(1): The Company's 2025 Business Report.
(2): Audit Committee's Review Report on the 2025 Financial Statements.
(3): Report on Company Losses Reaching One Half of Paid-in Capital.
(4): Report on the Execution Status of the First Private Placement of Common Shares in 2025.
(5): The Company's 2025 Directors' Remuneration Report.
6. Agenda Item 2: Approval Matters
(1): 2025 Business Report and Financial Statements.
(2): 2025 Loss Compensation Plan.
7. Agenda Item 3: Election Matters
(1): Re-election of nine directors (including three independent directors).
8. Agenda Item 4: Discussion Matters
(1): Lifting the non-compete restriction for newly appointed directors.
(2): Revision of "Procedures for Acquisition or Disposal of Assets".
(3): Revision of "Articles of Incorporation".
(4): The Company plans to conduct the first private placement of common shares in 2026.
(5): Issuance of restricted stock units for employees in 2026.
9. Ad Hoc Motions:
10. Book Closure Start Date: 2026/03/22
11. Book Closure End Date: 2026/05/20
12. Other Explanations: (1) Added discussion items: No. 3 "Revision of Articles of Incorporation" and No. 5 "Issuance of Restricted Stock Units for Employees in 2026".
(2) In accordance with Article 177-1 of the Company Act, the Company will adopt electronic voting for the shareholders' meeting. The voting period is from April 20, 2026, to May 17, 2026.
(3) The statistical verification institution for this Annual General Meeting of Shareholders is Grand Fortune Securities Co., Ltd. Stock Affairs Agency Department.
2. Date of Shareholders' Meeting: 2026/05/20
3. Location of Shareholders' Meeting: 8th Floor Conference Room, No. 65, Lane 77, Xing'ai Road, Neihu District, Taipei City
4. Method of Convening Shareholders' Meeting (Physical Shareholders' Meeting/Video-Assisted Shareholders' Meeting/Video Shareholders' Meeting): Physical Shareholders' Meeting
5. Agenda Item 1: Reporting Matters
(1): The Company's 2025 Business Report.
(2): Audit Committee's Review Report on the 2025 Financial Statements.
(3): Report on Company Losses Reaching One Half of Paid-in Capital.
(4): Report on the Execution Status of the First Private Placement of Common Shares in 2025.
(5): The Company's 2025 Directors' Remuneration Report.
6. Agenda Item 2: Approval Matters
(1): 2025 Business Report and Financial Statements.
(2): 2025 Loss Compensation Plan.
7. Agenda Item 3: Election Matters
(1): Re-election of nine directors (including three independent directors).
8. Agenda Item 4: Discussion Matters
(1): Lifting the non-compete restriction for newly appointed directors.
(2): Revision of "Procedures for Acquisition or Disposal of Assets".
(3): Revision of "Articles of Incorporation".
(4): The Company plans to conduct the first private placement of common shares in 2026.
(5): Issuance of restricted stock units for employees in 2026.
9. Ad Hoc Motions:
10. Book Closure Start Date: 2026/03/22
11. Book Closure End Date: 2026/05/20
12. Other Explanations: (1) Added discussion items: No. 3 "Revision of Articles of Incorporation" and No. 5 "Issuance of Restricted Stock Units for Employees in 2026".
(2) In accordance with Article 177-1 of the Company Act, the Company will adopt electronic voting for the shareholders' meeting. The voting period is from April 20, 2026, to May 17, 2026.
(3) The statistical verification institution for this Annual General Meeting of Shareholders is Grand Fortune Securities Co., Ltd. Stock Affairs Agency Department.
FAQ
When will Golden Biotechnology Corp.'s Annual General Meeting of Shareholders be held?
It will be held on May 20, 2026.
What are the main new agenda items added to this shareholders' meeting?
The main new agenda items are "Revision of Articles of Incorporation" and "Issuance of Restricted Stock Units for Employees in 2026."